These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

794 related items for PubMed ID: 17987649

  • 41. Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
    Rascol O, Dubois B, Caldas AC, Senn S, Del Signore S, Lees A, Parkinson REGAIN Study Group.
    Mov Disord; 2006 Dec; 21(12):2110-5. PubMed ID: 17013922
    [Abstract] [Full Text] [Related]

  • 42. [The use of antiparkinsonism drugs in 92 cases in Xi'an city].
    Zhe X, Qu QM, Wang RL, Cao HM, Qiao J, Guo F.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Oct; 30(10):1065-8. PubMed ID: 20193391
    [Abstract] [Full Text] [Related]

  • 43. Pathophysiology of motor fluctuations in Parkinson's disease.
    Widnell K.
    Mov Disord; 2005 Oct; 20 Suppl 11():S17-22. PubMed ID: 15822108
    [Abstract] [Full Text] [Related]

  • 44. Sleep disorders in Parkinson's disease.
    Kumar S, Bhatia M, Behari M.
    Mov Disord; 2002 Jul; 17(4):775-81. PubMed ID: 12210875
    [Abstract] [Full Text] [Related]

  • 45. Clinical course of patients with idiopathic Parkinson's disease.
    Roos RA, Jongen JC, van der Velde EA.
    Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
    [Abstract] [Full Text] [Related]

  • 46. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT, Goetz CG.
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [Abstract] [Full Text] [Related]

  • 47. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.
    Stereotact Funct Neurosurg; 2009 Jul; 87(1):45-9. PubMed ID: 19174620
    [Abstract] [Full Text] [Related]

  • 48. Levodopa effect upon functional balance of Parkinson's disease patients.
    Nova IC, Perracini MR, Ferraz HB.
    Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
    [Abstract] [Full Text] [Related]

  • 49. Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease.
    Zach H, Dirkx MF, Roth D, Pasman JW, Bloem BR, Helmich RC.
    Neurology; 2020 Sep 15; 95(11):e1461-e1470. PubMed ID: 32651292
    [Abstract] [Full Text] [Related]

  • 50. Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages.
    Picillo M, Amboni M, Erro R, Vitale C, Longo K, Pellecchia MT, Cozzolino A, Moccia M, Allocca R, Barone P.
    Parkinsonism Relat Disord; 2013 Dec 15; 19(12):1143-8. PubMed ID: 24041938
    [Abstract] [Full Text] [Related]

  • 51. Mokken scale analysis of the UPDRS: dimensionality of the Motor Section revisited.
    Stochl J, Boomsma A, van Duijn M, Brozová H, Růzická E.
    Neuro Endocrinol Lett; 2008 Feb 15; 29(1):151-8. PubMed ID: 18283252
    [Abstract] [Full Text] [Related]

  • 52. Parkinson's disease. Diagnosis and the initiation of therapy.
    Bhat V, Weiner WJ.
    Minerva Med; 2005 Jun 15; 96(3):145-54. PubMed ID: 16175158
    [Abstract] [Full Text] [Related]

  • 53. [Motor symptoms in Parkinson disease].
    Larsen JP, Beiske AG, Bekkelund SI, Dietrichs E, Tysnes OB, Vilming ST, Aasly JO.
    Tidsskr Nor Laegeforen; 2008 Sep 25; 128(18):2068-71. PubMed ID: 18846123
    [Abstract] [Full Text] [Related]

  • 54. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR.
    Mov Disord; 2009 Jul 30; 24(10):1468-74. PubMed ID: 19425079
    [Abstract] [Full Text] [Related]

  • 55. Assessment of rest tremor in Parkinson's disease.
    Budzianowska A, Honczarenko K.
    Neurol Neurochir Pol; 2008 Jul 30; 42(1):12-21. PubMed ID: 18365958
    [Abstract] [Full Text] [Related]

  • 56. Parkinsonian action tremor: interference with object manipulation and lacking levodopa response.
    Raethjen J, Pohle S, Govindan RB, Morsnowski A, Wenzelburger R, Deuschl G.
    Exp Neurol; 2005 Jul 30; 194(1):151-60. PubMed ID: 15899252
    [Abstract] [Full Text] [Related]

  • 57. Rasagiline treatment effects on parkinsonian tremor.
    Lew MF.
    Int J Neurosci; 2013 Dec 30; 123(12):859-65. PubMed ID: 23767986
    [Abstract] [Full Text] [Related]

  • 58. Clinical spectrum of Parkinson's disease from Pakistan.
    Khealani BA, Baig SM.
    Singapore Med J; 2006 Dec 30; 47(12):1075-9. PubMed ID: 17139405
    [Abstract] [Full Text] [Related]

  • 59. Prevalence of Parkinson's disease in Northern Jordan.
    Alrefai A, Habahbih M, Alkhawajah M, Darwish M, Batayha W, Khader Y, El-Salem K.
    Clin Neurol Neurosurg; 2009 Dec 30; 111(10):812-5. PubMed ID: 19733962
    [Abstract] [Full Text] [Related]

  • 60. Dissociation of cardinal motor signs in Parkinson's disease patients.
    Koh SB, Kwon DY, Seo WK, Kim JH, Kim JH, Lee SH, Oh K, Kim BJ, Park KW.
    Eur Neurol; 2010 Dec 30; 63(5):307-10. PubMed ID: 20453513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.